CELG

Discussion in 'Options' started by oldnemesis, Jan 12, 2016.

  1. http://finance.yahoo.com/news/celgene-celg-drops-preliminary-results-153003722.html

    http://www.fool.com/investing/gener...ce=yahoo&utm_medium=feed&utm_campaign=article

    http://www.msn.com/en-us/money/stockdetails/fi-126.1.CELG.NAS

    http://stockcharts.com/h-sc/ui?s=celg

    Trade:
    With CELG at 104.47
    Jul 135/140 bear call spread for a net credit of $45
    Yield = 45/455 = 9.9% in 185 days or 19.5% annualized
    Prob = 84%
    Expectation = .84(45) - .13(455) - .03(228) = 37.8 - 59.2 - 6.84 = -28.2

    Price.......... Profit / Loss....... ROM %
    78.00................ 45.00............. 9.90%
    96.00................ 45.00............. 9.90%
    115.00.............. 45.00............. 9.90%
    135.00.............. 45.00............. 9.90%
    135.45................ 0.00............. 0.00%
    135.87............. (41.60).......... -8.32%
    140.00............. (455.00)........ -90.10%
    155.00............. (455.00)........ -90.10%
    175.00............. (455.00)........ -90.10%
     
    Last edited: Jan 12, 2016
  2. Zestilio

    Zestilio

    $CELG slithering to $110++ while some are kicking themselves for not having the balls to buy the lows today. Oh well... Bios need attn
     
  3. vanzandt

    vanzandt

    $76 now.
    Why does everyone hate this thing so much?
    Seems safe enough at this level. Even a falling chainsaw bounces eventually. I would think.
     
  4. Celgene suffered yet another setback when it received Refusal to File letter from the FDA regarding its New Drug Application (“NDA”) for multiple sclerosis candidate ozanimod.

    The key issues for the refusal to file centered on the completeness of the clinical pharmacology and the non-clinical portions of the NDA.
     
  5. vanzandt

    vanzandt

    Fish.... yeah that news broke on 2/27..... you can see that nice gap on the daily.... from $96 down to $89.... that was when that came out.

    This latest sell-off has to do with a VP resigning and something out of the FDA about the generic manufacturers whining that several big pharma are not ponying up their formulas.... or something like that.

    I like yesterday's volume.... we might finally have seen some capitulation. This is a solid steady eddy company that makes $'s and has a solid balance sheet. $75 is cheap. For grandma at least.
     
    ironchef likes this.
  6. ironchef

    ironchef

    Totally agree. For grandpa too.:D
     
    vanzandt likes this.